US Stock MarketDetailed Quotes

SCLXW SCILEX HOLDING COMPANY C/WTS 10/11/2027 (TO PUR COM)

Watchlist
  • 0.366
  • -0.034-8.51%
Close Mar 28 16:00 ET
0Market Cap0.00P/E (TTM)

About SCILEX HOLDING COMPANY C/WTS 10/11/2027 (TO PUR COM) Company

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTlido, a prescription lidocaine topical product approved by the FDA for the relief of neuropathic pain associated with PHN, which is a form of post-shingles nerve pain, and e GLOPERBA oral solutions, an FDA-approved prophylactic treatment for painful gout flares in adults. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Company Profile

SymbolSCLXW
Company NameSCILEX HOLDING COMPANY C/WTS 10/11/2027 (TO PUR COM)
Listing Date03/04/2021
Founded2020
CEOMr. Jaisim Shah
MarketNASDAQ
Employees105
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address960 San Antonio Road
CityPalo Alto
ProvinceCalifornia
CountryUnited States of America
Zip Code94303
Phone1-650-516-4310

Company Executives

  • Name
  • Position
  • Salary
  • Jaisim Shah
  • Chief Executive Officer, President and Director
  • 7.37M
  • Hoi Stephen Ma
  • Chief Financial Officer, Senior Vice President, Secretary and Principal Accounting Officer
  • 1.90M
  • Dr. Yue Alexander Wu, PhD
  • Independent Director
  • 285.67K
  • Dorman Followwill
  • Independent Director
  • 750.00K
  • David Jakob Lemus
  • Independent Director
  • 750.00K
  • Dr. Jay Chun, M.D.,PhD
  • Independent Director
  • 277.43K
  • Dr. Henry Ji,PhD
  • Executive Chairperson of the Board
  • 33.92M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg